how quickly does tirzepatide kick in When In? Timeline for Results How Long Does It Take

2011;17(12):CR677-82

For patients with a history of heart disease, this proven benefit may tip the clinical balance toward semaglutide

SolisFirst Summit Wealth Management | Wells Fargo Advisors Financial NetworkSacramentoCalifornia - Northern CA (High Net Worth)$500K$1.1B$1-5M$250K-10MScott MacDonaldMerrill Wealth ManagementModestoCalifornia - Northern CA (High Net Worth)$25K$1.8B$275-800K$250-800KJennifer EllisonB|O|SRedwood CityCalifornia - Northern CA (High Net Worth)$5M$8.8B$10-150M$5-65MChris WestWells Fargo AdvisorsWalnut CreekCalifornia - Northern CA (High Net Worth)$250K$1.6B$3-15M$2-5MJoshua StrawnUBS Wealth ManagementSacramentoCalifornia - Northern CA (High Net Worth)$1M$1.9B$1-10M$2-5MStephen BesseRaymond James & AssociatesWalnut CreekCalifornia - Northern CA (High Net Worth)$0$1.1B$1-30M$250K-25MSterling DalatriMorgan Stanley Wealth ManagementSacramentoCalifornia - Northern CA (High Net Worth)$1M$916M$3-15M$1-25MMatt DamelioMerrill Wealth ManagementPalo AltoCalifornia - Northern CA (High Net Worth)$1M$2.3B$3-20M$3-7MGrant MatthewsUBS Wealth ManagementPalo AltoCalifornia - Northern CA (High Net Worth)$3M$1.2B$7-25M$3-25MDavid GambelinMorgan Stanley Wealth ManagementSan JoseCalifornia - Northern CA (High Net Worth)$1M$770M$3-6M$1-5MNathan BennettSummit Financial Group | Raymond JamesSan RamonCalifornia - Northern CA (High Net Worth)$0$3.5B$2-15M$1.5-6MLawrence OlinWells Fargo AdvisorsWalnut CreekCalifornia - Northern CA (High Net Worth)$1M$1.8B$3-15M$3-15MMorgan BeckerMorgan Stanley Wealth ManagementWalnut CreekCalifornia - Northern CA (High Net Worth)$5M$1.4B$3-20M$3-15MBobby AdamsAmeriprise Financial ServicesSan JoseCalifornia - Northern CA (High Net Worth)$0$679M$1-30M$500K-25MLouis BatmaleAlders Financial SolutionsNovatoCalifornia - Northern CA (High Net Worth)$250K$825M$1-5M$500K-1MKevin HaarbergEdward JonesWoodlandCalifornia - Northern CA (High Net Worth)$1M$751M$2-9M$1-4.2MProfile SpotlightTrung LamJ.P

T for all your care and encouragement

A Phase 2 trial published in the New England Journal of Medicine (Jastreboff et al., 2023) reported mean weight reductions of approximately 1724% over 48 weeks in adults with obesity but without type 2 diabetes, across the higher dose groups studied

GLP-1 (glucagon-like peptide-1) therapy is one of the most effective medical advancements in weight management today